{"id":"W2955997569","doi":"10.1093/jjco/hyz085","title":"An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION","year":2019,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Durvalumab; Olaparib; Oncology; Gynecologic oncology; Internal medicine; Clinical endpoint; Ovarian cancer; Biomarker; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Chemotherapy; Targeted therapy; Clinical trial; Cancer; Nivolumab; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003466063,0.001595334,0.001993254,0.0004987766,0.0006280449,0.0009154179,0.0008568175,0.001066594,0.003235237],"category_scores_gemma":[0.001126503,0.0009165796,0.001464126,0.0008351766,0.0007388713,0.001025076,0.0009138706,0.001685387,0.001252484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007813128,"about_ca_system_score_gemma":0.001746839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001138066,"about_ca_topic_score_gemma":0.002070228,"domain_scores_codex":[0.9988872,0.0006502892,0.00006730057,0.0001615341,0.00007679944,0.0001569077],"domain_scores_gemma":[0.9988849,0.00007771431,0.0001707984,0.0001968518,0.00005397404,0.0006159346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7537226,0.04850873,0.1171572,0.001088374,0.003182087,0.0004503967,0.0004708659,0.0007129173,0.0199045,0.0004219412,0.006070451,0.04830994],"study_design_scores_gemma":[0.5594937,0.1980287,0.2264555,0.00009571017,0.002784299,0.0003642102,0.0001848527,0.0008311056,0.001897595,0.0003936737,0.009382872,0.00008776822],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876507,0.001791792,0.000418792,0.0004314769,0.0001080792,0.00459841,0.003214389,0.00003920413,0.001747256],"genre_scores_gemma":[0.9718356,0.001688719,0.002108027,0.001955575,0.0004378087,0.007748931,0.009878709,0.00005430684,0.004292268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003466063,"threshold_uncertainty_score":0.01833057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0878502810883729,"score_gpt":0.4397574802038167,"score_spread":0.3519071991154438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}